J0583 BivalirudinInjection, bivalirudin, 1 mg
J0583 payment limit: $0.165 per 1 MG, effective October 1, 2026 through December 31, 2026, based on 2Q26 ASP data. Coinsurance 20%.
16729-0275-67 Bivalirudin, Accord Healthcare Inc: 2500 billing units per package (10 VIAL, SINGLE-USE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-USE)83634-0400-10 Bivalirudin, Avenacy Inc.: 2500 billing units per package (10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE)72572-0035-10 Bivalirudin, Civica, Inc.: 2500 billing units per package (10 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE)55111-0652-37 Bivalirudin, Dr. Reddy's Laboratories Inc.: 2500 billing units per package (10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION in 1 VIAL, SINGLE-DOSE)55150-0210-10 Bivalirudin, Eugia US LLC: 2500 billing units per package (10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE)63323-0562-10 Bivalirudin, FreseniUS Kabi USA, LLC: 2500 billing units per package (10 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE)63323-0562-15 Bivalirudin, FreseniUS Kabi USA, LLC: 2500 billing units per package (10 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE)71288-0427-11 Bivalirudin, Meitheal Pharmaceuticals Inc.: 2500 billing units per package (10 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE)71288-0427-92 Bivalirudin, Meitheal Pharmaceuticals Inc.: 2500 billing units per package (10 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE)67457-0256-10 Bivalirudin, Mylan Institutional LLC: 2500 billing units per package (10 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE)00781-3158-95 Bivalirudin, Sandoz Inc.: 2500 billing units per package (10 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE)00781-9158-95 Bivalirudin, Sandoz Inc.: 2500 billing units per package70436-0025-82 Bivalirudin, Slate Run Pharmaceuticals: 2500 billing units per package (10 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 CARTON)Status E: excluded from the PFS by regulation.
1 of 1 payer prior-auth lists that name J0583 require prior authorization or set conditions: Rocky Mountain Health Plans.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| Rocky Mountain Health Plans | Rocky Mountain Medicare Advantage D-SNP | CO | prior auth required | Feb 1, 2025 | Rocky Mountain Health Plans Medicare Advantage Dual-Special Needs Plans – prior authorization Effective February 1, 2025 |
J0583 appears in 1 coverage policy from Aetna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Injectable Medications (0020) | listed, no stance (range J0278-J2543) | Mar 5, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.